{"product_id":"2022-asia-pacific-immunoassay-analyzers-and-reagents-in-18-countries-supplier-shares-and-competitive-analysis-volume-and-sales-segment-forecasts-for-100-abused-drugs-cancer-diagnostic-endocrine-function-immunoproteins-tdms-and-special-chemistry-test","title":"2022 Asia-Pacific Immunoassay Analyzers and Reagents in 18 Countries—Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Test","description":"\u003cp\u003e2022 Asia-Pacific Immunoassay Analyzers and Reagents in 18 Countries—Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests Performed in Hospitals, Commercial\/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities in Suppliers\u003c\/p\u003e \n\n\u003cp\u003eThis new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC\/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.\u003c\/p\u003e\n\n\u003cp\u003eRationale\u003c\/p\u003e\n\n\u003cp\u003eClinical chemistry and immunoassay markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.\u003c\/p\u003e\n\n\u003cp\u003eCountry Analyses\u003c\/p\u003e\n\n\u003cp\u003eAustralia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam\u003c\/p\u003e\n\n\u003cp\u003eGlobal Market Overview\u003c\/p\u003e\n\n\u003cp\u003eEstimates of facilities performing clinical chemistry and immunoassay tests in major countries.\u003c\/p\u003e\n\n\u003cp\u003eTest volume and sales projections.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e\n\n\u003cp\u003eComprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.\u003c\/p\u003e\n\n\u003cp\u003eTest volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.\u003c\/p\u003e\n\n\u003cp\u003eIndividual Tests Analyzed in the Report\u003c\/p\u003e\n\n\u003cp\u003eClinical Chemistry\u003c\/p\u003e\n\n\u003cp\u003eAlbumin, Alkaline Phosphatase, ALT\/SGPT, Ammonia, Amylase, AST\/SGOT, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcium, Carbon Dioxide\/Bicarbonate, Cardio CRP, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Triglycerides, Troponin, Uric Acid\u003c\/p\u003e\n\n\u003cp\u003eTherapeutic Drug Monitoring (TDM)\u003c\/p\u003e\n\n\u003cp\u003eAmikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA\/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin\u003c\/p\u003e\n\n\u003cp\u003eEndocrine Function\u003c\/p\u003e\n\n\u003cp\u003eCortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH\/IO PTH, Prolactin, T3, T3 Free, T3 Uptake, T4, T4 Free, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH\u003c\/p\u003e\n\n\u003cp\u003eTumor Markers and Special Chemistry\u003c\/p\u003e\n\n\u003cp\u003eAFP, CA 15-3\/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12\u003c\/p\u003e\n\n\u003cp\u003eImmunoproteins\u003c\/p\u003e\n\n\u003cp\u003eC3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis\u003c\/p\u003e\n\n\u003cp\u003eDrugs of Abuse\u003c\/p\u003e\n\n\u003cp\u003eAmphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids\/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003eAnalysis of current and emerging clinical chemistry and immunoassay tests.\u003c\/p\u003e\n\n\u003cp\u003eReview of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume\/POC analyzers.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003eAssessment of current and emerging technologies, and their potential market applications.\u003c\/p\u003e\n\n\u003cp\u003eCompanies developing or marketing new technologies and products by test.\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003eNew product development opportunities with significant market appeal.\u003c\/p\u003e\n\n\u003cp\u003eAlternative market penetration strategies.\u003c\/p\u003e\n\n\u003cp\u003ePotential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e\n\n\u003cp\u003eStrategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R\u0026amp;D.\u003c\/p\u003e\n\n\u003cp\u003eAbbott Laboratories\u003cbr\u003e\nAgilent Technologies\u003cbr\u003e\nBeckman Coulter\/Danaher\u003cbr\u003e\nbioMerieux\u003cbr\u003e\nBio-Rad\u003cbr\u003e\nDiaSorin\u003cbr\u003e\nEiken Chemical\u003cbr\u003e\nFujifilm Wako\u003cbr\u003e\nFujirebio\u003cbr\u003e\nGrifols\u003cbr\u003e\nInstrumentation Laboratory\/Werfen\u003cbr\u003e\nKyowa Medex\u003cbr\u003e\nOrthoQuidel\u003cbr\u003e\nPerkinElmer\u003cbr\u003e\nQuest Diagnostics\u003cbr\u003e\nRoche\u003cbr\u003e\nSiemens Healthineers\u003cbr\u003e\nSysmex\u003cbr\u003e\nThermo Fisher\u003cbr\u003e\nTosoh\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ - \/ MCW16233765","offer_id":47650823864626,"sku":null,"price":11400.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2022-asia-pacific-immunoassay-analyzers-and-reagents-in-18-countries-supplier-shares-and-competitive-analysis-volume-and-sales-segment-forecasts-for-100-abused-drugs-cancer-diagnostic-endocrine-function-immunoproteins-tdms-and-special-chemistry-test","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}